An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

September 17, 2024

Primary Completion Date

May 4, 2027

Study Completion Date

September 15, 2027

Conditions
Colitis, Ulcerative
Interventions
DRUG

Etrasimod

As provided in real world practice

Trial Locations (14)

10016

RECRUITING

NYU Langone Health, New York

20815

RECRUITING

MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase

21061

RECRUITING

Woodholme Gastroenterology Associates PA, Glen Burnie

27599

RECRUITING

University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill

30078

RECRUITING

EBGS Clinical Research Center, Snellville

33024

RECRUITING

Best Choice Medical Research Service, Pembroke Pines

33558

RECRUITING

Gastro Florida, Lutz

33756

RECRUITING

Gastro Florida, Clearwater

73102

RECRUITING

Hightower Clinical Trial Services, Oklahoma City

77084

NOT_YET_RECRUITING

BI Research Center, Houston

80120

NOT_YET_RECRUITING

Rocky Mountain Gastroenterology, Littleton

85206

RECRUITING

Reddy GI Associates, Mesa

91355

RECRUITING

Amicis Research Center, Valencia

98405

RECRUITING

Washington Gastroenterology, Tacoma

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY